A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers

CompletedOBSERVATIONAL
Enrollment

687

Participants

Timeline

Start Date

December 15, 2018

Primary Completion Date

January 6, 2020

Study Completion Date

January 30, 2020

Conditions
Breast CancerEarly Detection of Cancer
Interventions
DIAGNOSTIC_TEST

Thermalytix

Thermalytix is an Artificial intelligence based automated breast screening solution that analyzes thermal distribution on the breast to generate a breast health score automatically. Thermal imaging was performed by a trained technician to capture thermal images of the participant in five views. These thermal images were uploaded to Thermalytix software on the cloud where it was automatically analyzed by AI-based Thermalytix computer-aided detection (CADe) engine. This CADe engine analyzes uploaded thermal images and outputs an interpretation report for each participant with quantitative scores corresponding to computed probability of malignancy based on the structural, vascular, areolar, thermal properties of the observed abnormality. Thermalytix also generates annotated images with markings of abnormal regions and an overall Thermalytix score suggesting likelihood of breast malignancy. The locked AI model Thermalytix algorithm version 3, dated December 2018 was used for the analysis.

Trial Locations (1)

110017

Max Healthcare Insititute Limited, New Delhi

All Listed Sponsors
collaborator

Max Healthcare Insititute Limited

OTHER

lead

Niramai Health Analytix Private Limited

INDUSTRY

NCT04688086 - A Prospective Study to Evaluate Clinical Performance of Thermalytix in Detecting Breast Cancers | Biotech Hunter | Biotech Hunter